Regeneron Pharmaceuticals, Inc. (REGN)
USD 714.62
(-3.43%)
USD 714.62
(-3.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.7 Billion USD | 0.06% |
| 2022 | 2.7 Billion USD | 0.06% |
| 2021 | 2.69 Billion USD | 0.15% |
| 2020 | 2.69 Billion USD | 277.6% |
| 2019 | 713.9 Million USD | 0.76% |
| 2018 | 708.5 Million USD | 0.72% |
| 2017 | 703.45 Million USD | 46.21% |
| 2016 | 481.12 Million USD | 28.13% |
| 2015 | 375.51 Million USD | -18.2% |
| 2014 | 459.06 Million USD | -9.19% |
| 2013 | 505.51 Million USD | 10.54% |
| 2012 | 457.32 Million USD | 5.0% |
| 2011 | 435.53 Million USD | 172.16% |
| 2010 | 160.03 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 5.09 Million USD | -97.48% |
| 2007 | 202.29 Million USD | 1.15% |
| 2006 | 200 Million USD | 0.0% |
| 2005 | 200 Million USD | 0.0% |
| 2004 | 200 Million USD | -6.46% |
| 2003 | 213.81 Million USD | 6.83% |
| 2002 | 200.15 Million USD | -0.21% |
| 2001 | 200.57 Million USD | 7381.39% |
| 2000 | 2.68 Million USD | -34.61% |
| 1999 | 4.1 Million USD | -2.38% |
| 1998 | 4.2 Million USD | -25.0% |
| 1997 | 5.6 Million USD | -35.63% |
| 1996 | 8.7 Million USD | -8.42% |
| 1995 | 9.5 Million USD | -22.76% |
| 1994 | 12.3 Million USD | 64.0% |
| 1993 | 7.5 Million USD | 10.29% |
| 1992 | 6.8 Million USD | 142.86% |
| 1991 | 2.8 Million USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.7 Billion USD | 0.01% |
| 2024 Q1 | 2.7 Billion USD | 0.01% |
| 2024 Q3 | 2.7 Billion USD | 0.01% |
| 2023 Q1 | 2.7 Billion USD | 0.01% |
| 2023 Q4 | 2.7 Billion USD | 0.01% |
| 2023 FY | 2.7 Billion USD | 0.06% |
| 2023 Q2 | 2.7 Billion USD | 0.01% |
| 2023 Q3 | 2.7 Billion USD | 0.01% |
| 2022 Q2 | 2.7 Billion USD | 0.01% |
| 2022 Q3 | 2.7 Billion USD | 0.01% |
| 2022 FY | 2.7 Billion USD | 0.06% |
| 2022 Q1 | 2.7 Billion USD | 0.03% |
| 2022 Q4 | 2.7 Billion USD | 0.01% |
| 2021 FY | 2.69 Billion USD | 0.15% |
| 2021 Q2 | 2.69 Billion USD | 0.03% |
| 2021 Q1 | 2.69 Billion USD | 0.04% |
| 2021 Q3 | 2.69 Billion USD | 0.04% |
| 2021 Q4 | 2.69 Billion USD | 0.04% |
| 2020 Q2 | 2.21 Billion USD | 209.83% |
| 2020 FY | 2.69 Billion USD | 277.6% |
| 2020 Q1 | 715.2 Million USD | 0.18% |
| 2020 Q4 | 2.69 Billion USD | 0.03% |
| 2020 Q3 | 2.69 Billion USD | 21.61% |
| 2019 FY | 713.9 Million USD | 0.76% |
| 2019 Q1 | 709.9 Million USD | 0.2% |
| 2019 Q2 | 711.3 Million USD | 0.2% |
| 2019 Q4 | 713.9 Million USD | 0.17% |
| 2019 Q3 | 712.7 Million USD | 0.2% |
| 2018 Q4 | 708.5 Million USD | 0.18% |
| 2018 FY | 708.5 Million USD | 0.72% |
| 2018 Q3 | 707.2 Million USD | 0.18% |
| 2018 Q2 | 705.9 Million USD | 0.18% |
| 2018 Q1 | 704.64 Million USD | 0.17% |
| 2017 FY | 703.45 Million USD | 46.21% |
| 2017 Q4 | 703.45 Million USD | 0.16% |
| 2017 Q1 | 707.6 Million USD | 47.07% |
| 2017 Q2 | 701.17 Million USD | -0.91% |
| 2017 Q3 | 702.31 Million USD | 0.16% |
| 2016 Q3 | 382.22 Million USD | 5.73% |
| 2016 Q4 | 481.12 Million USD | 25.87% |
| 2016 Q2 | 361.52 Million USD | -0.2% |
| 2016 Q1 | 362.23 Million USD | -3.54% |
| 2016 FY | 481.12 Million USD | 28.13% |
| 2015 Q4 | 375.51 Million USD | -4.9% |
| 2015 Q3 | 394.86 Million USD | 1.76% |
| 2015 Q1 | 472.47 Million USD | 2.92% |
| 2015 FY | 375.51 Million USD | -18.2% |
| 2015 Q2 | 388.04 Million USD | -17.87% |
| 2014 FY | 459.06 Million USD | -9.19% |
| 2014 Q1 | 531.11 Million USD | 5.06% |
| 2014 Q2 | 517.84 Million USD | -2.5% |
| 2014 Q3 | 565.31 Million USD | 9.17% |
| 2014 Q4 | 459.06 Million USD | -18.79% |
| 2013 Q4 | 505.51 Million USD | 4.84% |
| 2013 FY | 505.51 Million USD | 10.54% |
| 2013 Q1 | 462.74 Million USD | 1.19% |
| 2013 Q2 | 473.3 Million USD | 2.28% |
| 2013 Q3 | 482.17 Million USD | 1.87% |
| 2012 Q1 | 440.83 Million USD | 1.22% |
| 2012 Q2 | 446.23 Million USD | 1.22% |
| 2012 Q3 | 451.73 Million USD | 1.23% |
| 2012 FY | 457.32 Million USD | 5.0% |
| 2012 Q4 | 457.32 Million USD | 1.24% |
| 2011 Q2 | 160.33 Million USD | 0.11% |
| 2011 FY | 435.53 Million USD | 172.16% |
| 2011 Q4 | 435.53 Million USD | 171.53% |
| 2011 Q3 | 160.4 Million USD | 0.04% |
| 2011 Q1 | 160.15 Million USD | 0.08% |
| 2010 Q1 | 156.89 Million USD | 0.0% |
| 2010 FY | 160.03 Million USD | 0.0% |
| 2010 Q4 | 160.03 Million USD | 0.64% |
| 2010 Q3 | 159.01 Million USD | 0.77% |
| 2010 Q2 | 157.8 Million USD | 0.58% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q1 | - USD | -100.0% |
| 2009 Q2 | 62.92 Million USD | 0.0% |
| 2009 Q3 | 62.57 Million USD | -0.56% |
| 2008 Q1 | 200 Million USD | -1.13% |
| 2008 FY | 5.09 Million USD | -97.48% |
| 2008 Q2 | 118.65 Million USD | -40.67% |
| 2008 Q3 | 117.5 Million USD | -0.97% |
| 2008 Q4 | 5.09 Million USD | -95.67% |
| 2007 Q1 | 200 Million USD | 0.0% |
| 2007 FY | 202.29 Million USD | 1.15% |
| 2007 Q3 | 200 Million USD | 0.0% |
| 2007 Q2 | 200 Million USD | 0.0% |
| 2007 Q4 | 202.29 Million USD | 1.15% |
| 2006 Q1 | 200 Million USD | 0.0% |
| 2006 Q3 | 200 Million USD | 0.0% |
| 2006 FY | 200 Million USD | 0.0% |
| 2006 Q4 | 200 Million USD | 0.0% |
| 2006 Q2 | 200 Million USD | 0.0% |
| 2005 Q4 | 200 Million USD | 0.0% |
| 2005 Q3 | 200 Million USD | 0.0% |
| 2005 FY | 200 Million USD | 0.0% |
| 2005 Q2 | 200 Million USD | 0.0% |
| 2005 Q1 | 200 Million USD | 0.0% |
| 2004 Q3 | 200 Million USD | 0.0% |
| 2004 FY | 200 Million USD | -6.46% |
| 2004 Q4 | 200 Million USD | 0.0% |
| 2004 Q1 | 200 Million USD | -6.46% |
| 2004 Q2 | 200 Million USD | 0.0% |
| 2003 Q3 | 209.29 Million USD | 2.02% |
| 2003 Q2 | 205.14 Million USD | 2.54% |
| 2003 Q4 | 213.81 Million USD | 2.16% |
| 2003 FY | 213.81 Million USD | 6.83% |
| 2003 Q1 | 200.06 Million USD | -0.04% |
| 2002 Q1 | 200.46 Million USD | -0.06% |
| 2002 Q3 | 200.23 Million USD | -0.04% |
| 2002 Q2 | 200.32 Million USD | -0.07% |
| 2002 FY | 200.15 Million USD | -0.21% |
| 2002 Q4 | 200.15 Million USD | -0.04% |
| 2001 Q1 | 2.45 Million USD | -8.58% |
| 2001 Q4 | 200.57 Million USD | 9147.4% |
| 2001 Q3 | 2.16 Million USD | -6.39% |
| 2001 Q2 | 2.31 Million USD | -5.47% |
| 2001 FY | 200.57 Million USD | 7381.39% |
| 2000 FY | 2.68 Million USD | -34.61% |
| 2000 Q4 | 2.68 Million USD | -10.72% |
| 2000 Q3 | 3 Million USD | -12.75% |
| 2000 Q2 | 3.44 Million USD | -11.11% |
| 2000 Q1 | 3.87 Million USD | -5.56% |
| 1999 Q2 | 3.7 Million USD | -5.13% |
| 1999 FY | 4.1 Million USD | -2.38% |
| 1999 Q4 | 4.1 Million USD | 24.24% |
| 1999 Q3 | 3.3 Million USD | -10.81% |
| 1999 Q1 | 3.9 Million USD | -7.14% |
| 1998 Q4 | 4.2 Million USD | -6.67% |
| 1998 Q1 | 4.8 Million USD | -14.29% |
| 1998 Q2 | 4.8 Million USD | 0.0% |
| 1998 Q3 | 4.5 Million USD | -6.25% |
| 1998 FY | 4.2 Million USD | -25.0% |
| 1997 Q2 | 7.3 Million USD | -6.41% |
| 1997 Q3 | 6.8 Million USD | -6.85% |
| 1997 Q4 | 5.6 Million USD | -17.65% |
| 1997 Q1 | 7.8 Million USD | -10.34% |
| 1997 FY | 5.6 Million USD | -35.63% |
| 1996 Q2 | 8.6 Million USD | -1.15% |
| 1996 Q1 | 8.7 Million USD | -8.42% |
| 1996 FY | 8.7 Million USD | -8.42% |
| 1996 Q3 | 9 Million USD | 4.65% |
| 1996 Q4 | 8.7 Million USD | -3.33% |
| 1995 FY | 9.5 Million USD | -22.76% |
| 1995 Q1 | 8.7 Million USD | -29.27% |
| 1995 Q3 | 10.3 Million USD | -6.36% |
| 1995 Q2 | 11 Million USD | 26.44% |
| 1995 Q4 | 9.5 Million USD | -7.77% |
| 1994 FY | 12.3 Million USD | 64.0% |
| 1994 Q4 | 12.3 Million USD | 19.42% |
| 1994 Q2 | 9.4 Million USD | -21.01% |
| 1994 Q1 | 11.9 Million USD | 58.67% |
| 1994 Q3 | 10.3 Million USD | 9.57% |
| 1993 Q2 | 7.8 Million USD | 1.3% |
| 1993 Q4 | 7.5 Million USD | -2.6% |
| 1993 FY | 7.5 Million USD | 10.29% |
| 1993 Q3 | 7.7 Million USD | -1.28% |
| 1993 Q1 | 7.7 Million USD | 13.24% |
| 1992 Q2 | 5.7 Million USD | 18.75% |
| 1992 FY | 6.8 Million USD | 142.86% |
| 1992 Q4 | 6.8 Million USD | 9.68% |
| 1992 Q1 | 4.8 Million USD | 71.43% |
| 1992 Q3 | 6.2 Million USD | 8.77% |
| 1991 Q3 | 800 Thousand USD | 100.0% |
| 1991 Q2 | 400 Thousand USD | 0.0% |
| 1991 FY | 2.8 Million USD | 0.0% |
| 1991 Q4 | 2.8 Million USD | 250.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -1078.083% |
| IO Biotech, Inc. | 2.49 Million USD | -108276.103% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -1262937.383% |
| Organovo Holdings, Inc. | 1.39 Million USD | -193795.265% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -5530695.989% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -1648341.455% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -27444.074% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -38380.923% |
| Savara Inc. | 26.73 Million USD | -10008.834% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -400329.63% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -10693.467% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -12842.3% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -31225639.372% |
| Soligenix, Inc. | 3.49 Million USD | -77245.91% |
| Aptose Biosciences Inc. | 1 Million USD | -267565.274% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -13468.094% |
| Century Therapeutics, Inc. | 48.17 Million USD | -5511.052% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -6359.623% |
| Precision BioSciences, Inc. | 31.26 Million USD | -8544.301% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -1350.272% |
| Kura Oncology, Inc. | 17.2 Million USD | -15614.535% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -1973842.7% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -2824.172% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -94012.117% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -19242.35% |
| Autolus Therapeutics plc | 52.96 Million USD | -5002.989% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -49449.038% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -49322.198% |
| GRI Bio, Inc. | 14 Thousand USD | -19306328.571% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -21655.473% |
| IGM Biosciences, Inc. | 40.5 Million USD | -6572.839% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -1404.721% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -45657.119% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -326793.586% |
| Opthea Limited | 200.62 Million USD | -1247.214% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -4537.704% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -4570.48% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -23668.027% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -43742.66% |
| Surrozen, Inc. | 3.37 Million USD | -79891.122% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -86114.183% |
| Ovid Therapeutics Inc. | 46 Million USD | -5775.649% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -1909.531% |
| Acelyrin, Inc. | 1.19 Million USD | -226273.534% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -3095.371% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -1293029.844% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -8845.261% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -4254.249% |
| ADMA Biologics, Inc. | 141.41 Million USD | -1811.284% |
| PureTech Health plc | 25.51 Million USD | -10494.622% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -849868.553% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -154616.657% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -20729.995% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -3092.125% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -1094191.498% |
| ChromaDex Corporation | 3.27 Million USD | -82380.928% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -434447.743% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -1322.998% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -2494.402% |
| Better Therapeutics, Inc. | 14.88 Million USD | -18064.651% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -8728.967% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -2336.626% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -6993.481% |
| Seer, Inc. | 28.25 Million USD | -9464.74% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -43992.985% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -42714.827% |
| Gritstone bio, Inc. | 104.77 Million USD | -2479.718% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -96917.229% |
| Avid Bioservices, Inc. | 207.83 Million USD | -1200.509% |
| Insmed Incorporated | 1.2 Billion USD | -124.494% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -51938.891% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -69151.858% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -2510.59% |
| MediWound Ltd. | 6.71 Million USD | -40175.667% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -2566.003% |
| Fortress Biotech, Inc. | 88.59 Million USD | -2950.953% |
| OmniAb, Inc. | 25.56 Million USD | -10474.312% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -1163.415% |
| Zai Lab Limited | 15.15 Million USD | -17739.747% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -464.947% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -8417.9% |
| Veracyte, Inc. | 12.63 Million USD | -21300.633% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -49953.704% |
| FibroGen, Inc. | 170.45 Million USD | -1485.697% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -132786.004% |
| ContextLogic Inc. | 6 Million USD | -44948.333% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -1710596.203% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -41109.026% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 53.371% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -3861.454% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -7305035.135% |
| ImmuCell Corporation | 11.96 Million USD | -22481.933% |
| Fortrea Holdings Inc. | 1.67 Billion USD | -61.079% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -36840.003% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -96917.229% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -5896.716% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -6161.206% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -5875.108% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -5504.304% |
| Vaxxinity, Inc. | 15.16 Million USD | -17719.752% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -218.47% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -262982.077% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -19042453.191% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -12626.117% |
| Senti Biosciences, Inc. | 37.66 Million USD | -7075.968% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -1665098.346% |
| Apollomics, Inc. | 4.66 Million USD | -57889.702% |
| 89bio, Inc. | 27.1 Million USD | -9870.857% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -2246.858% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -599783.259% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -39038.43% |
| Ardelyx, Inc. | 55.98 Million USD | -4728.159% |
| Pluri Inc. | 29.61 Million USD | -9027.718% |
| Prothena Corporation plc | 11.83 Million USD | -22738.192% |
| Pulmatrix, Inc. | 8.75 Million USD | -30769.118% |
| Celularity Inc. | 65.41 Million USD | -4031.801% |
| MeiraGTx Holdings plc | 89.26 Million USD | -2927.984% |
| Omeros Corporation | 338.28 Million USD | -699.01% |
| Ainos, Inc. | 5.96 Million USD | -45223.629% |
| Humacyte, Inc. | 58.1 Million USD | -4551.671% |
| Mesoblast Limited | 118.92 Million USD | -2172.815% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -145766.163% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -55321.366% |
| Blueprint Medicines Corporation | 774.12 Million USD | -249.157% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -53764.089% |
| Summit Therapeutics Inc. | 106.09 Million USD | -2447.526% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -4272.351% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -2243.298% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -8467.578% |
| Cytokinetics, Incorporated | 755.77 Million USD | -257.635% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -20095.009% |
| Nutriband Inc. | 241.28 Thousand USD | -1120110.539% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -49340.278% |
| Roivant Sciences Ltd. | 499.74 Million USD | -440.852% |
| Evogene Ltd. | 1.13 Million USD | -237413.181% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -220364.927% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -4899564.642% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | -55.354% |
| BioLineRx Ltd. | 11.59 Million USD | -23218.954% |
| Atai Life Sciences N.V. | 16.47 Million USD | -16305.074% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -127395.283% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -2669.166% |
| MediciNova, Inc. | 215.92 Thousand USD | -1251671.44% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -108232.665% |
| MiMedx Group, Inc. | 48.09 Million USD | -5519.452% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -551.26% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -75189.694% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -165214.985% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -3309033.203% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -29404.421% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -18323.42% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -9759.201% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -21950.09% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -21512.826% |
| Allakos Inc. | 41.46 Million USD | -6418.51% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -24878.283% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -1789900.0% |
| BioAtla, Inc. | 2.46 Million USD | -109773.984% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -2741.539% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -48636.026% |
| Precigen, Inc. | 7.09 Million USD | -37985.106% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -2071.876% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -14176.132% |
| Incyte Corporation | 38.28 Million USD | -6959.576% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -6161.496% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -24167.373% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -1032.665% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -10278.605% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -774369.914% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -827758.484% |
| UroGen Pharma Ltd. | 100.21 Million USD | -2597.128% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -1379.023% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -780313.58% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -886096.721% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -39444.989% |
| Chimerix, Inc. | 2.14 Million USD | -125968.097% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -7501.968% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -1565228.685% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -10094.622% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -5750751.064% |
| OncoCyte Corporation | 2.86 Million USD | -94110.526% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -207940.849% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -12659853.162% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -1795202.682% |
| Purple Biotech Ltd. | 351 Thousand USD | -769956.98% |
| NextCure, Inc. | 6.6 Million USD | -40822.029% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -2661.048% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -51570.809% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -1079.322% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -279125.207% |
| NLS Pharmaceutics AG | 1.63 Million USD | -165341.874% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | -863.137% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -96639.442% |
| Daré Bioscience, Inc. | 5.31 Million USD | -50724.113% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -478289.381% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -5912.323% |
| BeiGene, Ltd. | 930.18 Million USD | -190.577% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -17290.381% |
| Alector, Inc. | 38.91 Million USD | -6845.115% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -236788.694% |
| Erasca, Inc. | 55.85 Million USD | -4738.791% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -13720.627% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -10476.381% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -689411.788% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | -138.377% |
| Histogen Inc. | 4.62 Million USD | -58379.013% |
| Fortress Biotech, Inc. | 88.59 Million USD | -2950.953% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -27335.039% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -4178.975% |
| Galecto, Inc. | 249 Thousand USD | -1085402.008% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -319.142% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -1844.113% |
| Molecular Templates, Inc. | 12.23 Million USD | -22000.572% |
| PDS Biotechnology Corporation | 23.85 Million USD | -11232.146% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -63692.778% |
| Amarin Corporation plc | 8.73 Million USD | -30836.248% |
| TG Therapeutics, Inc. | 110.79 Million USD | -2339.551% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -49981.527% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -106229.662% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -14236.71% |
| Onconetix, Inc. | 9.88 Million USD | -27241.314% |
| MacroGenics, Inc. | 33.97 Million USD | -7856.492% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -190379.211% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -12016.894% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -1186.232% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -24572.752% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -13219.371% |
| SciSparc Ltd. | 76 Thousand USD | -3556347.368% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -3195.543% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -821450.152% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -10584.244% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -1212.623% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -4955.362% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | -0.756% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -35197.896% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -4290217.46% |
| 2seventy bio, Inc. | 256.67 Million USD | -953.052% |
| Clene Inc. | 32.16 Million USD | -8304.278% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -123038.952% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -1325429.275% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -30893.005% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -16838.648% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -15617.276% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -9955.057% |
| Entera Bio Ltd. | 390 Thousand USD | -692951.282% |
| Trevena, Inc. | 35.23 Million USD | -7571.501% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -10610.917% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -9734.091% |
| INmune Bio, Inc. | 10.43 Million USD | -25797.288% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -561547.394% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -41508.682% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -6592339.024% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -9914.45% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -539505.473% |
| Jaguar Health, Inc. | 35.86 Million USD | -7437.368% |
| Clearside Biomedical, Inc. | 43 Million USD | -6185.668% |
| NexImmune, Inc. | 68.8 Thousand USD | -3928019.868% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -581168.817% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -220684.398% |
| Kronos Bio, Inc. | 28.27 Million USD | -9460.342% |
| Innoviva, Inc. | 449.07 Million USD | -501.88% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -462.118% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -13268.119% |
| Verastem, Inc. | 41.55 Million USD | -6404.079% |
| ProKidney Corp. | 4.41 Million USD | -61148.584% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -173719.936% |
| Imunon, Inc. | 1.62 Million USD | -166261.587% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -214415.873% |
| Statera Biopharma, Inc. | 16.26 Million USD | -16521.838% |
| ImmunityBio, Inc. | 883.67 Million USD | -205.87% |
| Korro Bio, Inc. | 33.2 Million USD | -8039.549% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -567.739% |
| Kineta, Inc. | 1.31 Million USD | -205131.587% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -75888.192% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -48061.544% |
| GT Biopharma, Inc. | 58 Thousand USD | -4660072.414% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -18612.96% |
| Celularity Inc. | 65.41 Million USD | -4031.801% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -5125.217% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -10878.027% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -3708.189% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -2349.211% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -705618.016% |
| Kodiak Sciences Inc. | 181.63 Million USD | -1388.119% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -2496.545% |
| Annexon, Inc. | 31.35 Million USD | -8520.316% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -3502.138% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -115309.906% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -38976.189% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -19415.523% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | -85.953% |
| Vor Biopharma Inc. | 35.66 Million USD | -7479.641% |
| Eyenovia, Inc. | 16.1 Million USD | -16680.112% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -675625.0% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -2324.343% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -5770.892% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -8315.53% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -274306.091% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -4624.937% |
| Immunocore Holdings plc | 84.03 Million USD | -3116.513% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -6844.758% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -3664.118% |
| Alkermes plc | 290.73 Million USD | -829.694% |
| Arcellx, Inc. | 97.62 Million USD | -2668.656% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -110177.618% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -5805.01% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -4158207.692% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -87034.107% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -214240.998% |
| Moolec Science SA | 2.64 Million USD | -102077.872% |
| Biomea Fusion, Inc. | 10.29 Million USD | -26151.943% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -3046.602% |
| Mereo BioPharma Group plc | 5.95 Million USD | -45311.626% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -5839.134% |
| Royalty Pharma plc | 6.13 Billion USD | 55.945% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -112427.061% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -162138.896% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -2345068.064% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -7889.654% |
| Humacyte, Inc. | 58.1 Million USD | -4551.671% |
| Structure Therapeutics Inc. | 5.45 Million USD | -49467.202% |
| NLS Pharmaceutics AG | 1.63 Million USD | -165341.874% |
| Genelux Corporation | 2.51 Million USD | -107200.516% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -3364729.2% |
| aTyr Pharma, Inc. | 15.09 Million USD | -17805.929% |
| Notable Labs, Ltd. | 2.04 Million USD | -131813.128% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -898727.457% |
| Mustang Bio, Inc. | 2.49 Million USD | -108102.562% |
| Immunovant, Inc. | 138 Thousand USD | -1958523.188% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -165546.785% |
| Vericel Corporation | 88.14 Million USD | -2966.494% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -80.284% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -9148.905% |
| Orgenesis Inc. | 22.62 Million USD | -11848.632% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -58543.957% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -1331377.833% |
| GH Research PLC | 343 Thousand USD | -787917.493% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -12982.135% |
| PepGen Inc. | 20.1 Million USD | -13344.588% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -470788.502% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -2676038.614% |
| Belite Bio, Inc | 886 Thousand USD | -304967.72% |
| Pharming Group N.V. | 171.54 Million USD | -1475.622% |
| XOMA Corporation | 124.45 Million USD | -2071.876% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -277690.339% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -1028.004% |
| Xencor, Inc. | 83.43 Million USD | -3139.567% |
| Replimune Group, Inc. | 75.86 Million USD | -3462.588% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -12571.23% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -28642.025% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -83997.698% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -15960.012% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -111728.713% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -214240.998% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -2391846.903% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -261808.915% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -85461.887% |
| scPharmaceuticals Inc. | 40.26 Million USD | -6612.111% |
| HilleVax, Inc. | 51.19 Million USD | -5179.823% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -4932.584% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -29664.343% |
| Immunic, Inc. | 1.33 Million USD | -202516.192% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -80286.106% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -670594.789% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -29664.343% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -126413.668% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -16055.042% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -125616.279% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -507.313% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -933083.264% |
| bluebird bio, Inc. | 330.32 Million USD | -718.252% |
| DBV Technologies S.A. | 14.38 Million USD | -18694.938% |
| Compugen Ltd. | 1.35 Million USD | -199966.617% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -25109.37% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -107929.576% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -43438.982% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -160119.324% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -6220.208% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -58101.981% |
| Benitec Biopharma Inc. | 284 Thousand USD | -951625.352% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -3096.618% |
| Adicet Bio, Inc. | 20.92 Million USD | -12817.702% |
| Prime Medicine, Inc. | 13.63 Million USD | -19726.157% |
| Aditxt, Inc. | 18.21 Million USD | -14736.436% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -2206.366% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -17562.55% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -334250.979% |
| PolyPid Ltd. | 11.77 Million USD | -22846.77% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -2855.346% |
| Invivyd, Inc. | 2.16 Million USD | -124745.266% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -76705549.979% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -4361.777% |
| CorMedix Inc. | 667.63 Thousand USD | -404748.779% |
| Instil Bio, Inc. | 86.05 Million USD | -3040.935% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -5234.11% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -1299.074% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -8871.984% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -48662.403% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -20259.295% |
| AbCellera Biologics Inc. | 77.38 Million USD | -3393.021% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -3141.315% |
| Surrozen, Inc. | 3.37 Million USD | -79891.122% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -10913.365% |
| Verona Pharma plc | 51.32 Million USD | -5165.834% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -448142.123% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -2070.307% |
| Evaxion Biotech A/S | 10.86 Million USD | -24766.42% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -3508.341% |
| Shattuck Labs, Inc. | 4.2 Million USD | -64224.131% |
| AlloVir, Inc. | 27.42 Million USD | -9754.169% |
| BioVie Inc. | 6.11 Million USD | -44126.842% |
| Codexis, Inc. | 22.36 Million USD | -11985.942% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -298233.333% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -1648341.455% |
| Agenus Inc. | 350.24 Million USD | -671.715% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -1204937.896% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -1152665.161% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -12741.6% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -13800.231% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -7118.073% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -125674.779% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -9388.188% |
| IN8bio, Inc. | 4.89 Million USD | -55140.139% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -201910.463% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -2448.367% |
| Liquidia Corporation | 3.5 Million USD | -77059.578% |
| Quantum-Si incorporated | 15.3 Million USD | -17562.55% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -3309033.203% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -24690.425% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -163414.822% |
| United Therapeutics Corporation | 700 Million USD | -286.129% |
| Solid Biosciences Inc. | 26.26 Million USD | -10190.881% |
| Immuneering Corporation | 4.46 Million USD | -60462.958% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -20259.295% |
| uniQure N.V. | 138.4 Million USD | -1852.835% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -23491.691% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -3064.136% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -568931.579% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -20243.971% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -1284005.108% |
| Cue Biopharma, Inc. | 14.69 Million USD | -18293.331% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -986359.854% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -8868.71% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -274306.091% |
| Immunome, Inc. | 1.65 Million USD | -163712.121% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -155866.532% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -27542.667% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -8847.262% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -746557.459% |
| Altimmune, Inc. | 671 Thousand USD | -402716.692% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -5120.473% |
| Rallybio Corporation | 392 Thousand USD | -689415.306% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -64547.214% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -461934.188% |
| Moolec Science SA | 2.64 Million USD | -102077.872% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -651201.205% |
| NeurAxis, Inc. | 224.26 Thousand USD | -1205152.832% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -342.397% |
| Lumos Pharma, Inc. | 6.58 Million USD | -40946.317% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -27542.667% |
| 180 Life Sciences Corp. | 1.32 Million USD | -204654.448% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -13468.094% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -15724.828% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -173719.936% |
| Nutriband Inc. | 241.28 Thousand USD | -1120110.539% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -327127.603% |
| argenx SE | 20 Million USD | -13414.5% |
| Neurogene Inc. | 16.25 Million USD | -16528.114% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -777.161% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -9370.236% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -15072.898% |
| Design Therapeutics, Inc. | 3.05 Million USD | -88519.672% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -1031541.221% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -18897.048% |
| Achilles Therapeutics plc | 4.61 Million USD | -58467.714% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -1903350.704% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -26365.289% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -623.24% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -8880.033% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -72993.509% |
| Palisade Bio, Inc. | 369 Thousand USD | -732393.225% |
| Beam Therapeutics Inc. | 173.17 Million USD | -1460.809% |
| AEON Biopharma, Inc. | 278 Thousand USD | -972166.187% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -806735.821% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -2528550.682% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -3462.917% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -4323.225% |
| Athira Pharma, Inc. | 1.58 Million USD | -170429.968% |
| Vaccinex, Inc. | 247 Thousand USD | -1094191.498% |
| HCW Biologics Inc. | 6.45 Million USD | -41793.884% |
| XOMA Corporation | 124.45 Million USD | -2071.876% |
| Nektar Therapeutics | 230.4 Million USD | -1073.129% |
| Arvinas, Inc. | 3.4 Million USD | -79397.059% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -165546.785% |
| Merus N.V. | 12.16 Million USD | -22124.141% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -2004.603% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -19466.382% |
| Rezolute, Inc. | 2.22 Million USD | -121215.081% |
| Clene Inc. | 32.16 Million USD | -8304.278% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -1543946.66% |
| BeyondSpring Inc. | 3.99 Million USD | -67557.071% |
| Synlogic, Inc. | 17.27 Million USD | -15546.31% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -207815.385% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -7722471.429% |
| Peak Bio, Inc. | 10.72 Million USD | -25109.37% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -5105.593% |
| Krystal Biotech, Inc. | 8.09 Million USD | -33293.876% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -1426.924% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -38200.978% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -1978683.841% |
| MannKind Corporation | 382.37 Million USD | -606.864% |
| Ikena Oncology, Inc. | 10.73 Million USD | -25071.354% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -660755.746% |
| Gossamer Bio, Inc. | 212.46 Million USD | -1172.168% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -1553290.805% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -29404.421% |
| Legend Biotech Corporation | 328.67 Million USD | -722.37% |
| Mural Oncology plc | 15 Million USD | -17908.528% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -5599.195% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -128548.263% |
| Champions Oncology, Inc. | 7.43 Million USD | -36278.197% |
| REGENXBIO Inc. | 89.29 Million USD | -2927.103% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -316140.726% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -488686.253% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -49824.27% |
| Vaxart, Inc. | 26.51 Million USD | -10094.237% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -17162.808% |
| Cellectis S.A. | 92.85 Million USD | -2810.945% |
| Longeveron Inc. | 2.04 Million USD | -132330.181% |
| Repare Therapeutics Inc. | 3.41 Million USD | -79163.93% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | -93.505% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -5701.211% |
| Revolution Medicines, Inc. | 87.94 Million USD | -2973.433% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -1562269.942% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -68275.917% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -852549.842% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -1544414.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -234.352% |
| Denali Therapeutics Inc. | 52.24 Million USD | -5073.906% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -18663.021% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -196617.613% |
| Cingulate Inc. | 3.13 Million USD | -86114.183% |
| Passage Bio, Inc. | 26.29 Million USD | -10179.531% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -40453.638% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -662375.49% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -302237.808% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -2973.433% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -13045.761% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -214415.873% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -110171.994% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -86448.191% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -333179.901% |
| OmniAb, Inc. | 25.56 Million USD | -10474.312% |
| Anew Medical, Inc. | 1.6 Million USD | -168304.984% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -9036.708% |
| Lipocine Inc. | 17.16 Thousand USD | -15745560.026% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -23124.781% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -7705.533% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -45657.119% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -4627.581% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -1331377.833% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -52231.075% |
| Ocugen, Inc. | 6.94 Million USD | -38841.075% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -19030.158% |
| Q32 Bio Inc. | 1.31 Million USD | -204975.873% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -402117.262% |
| Alumis Inc. Common Stock | 32.58 Million USD | -8196.194% |
| Equillium, Inc. | 824 Thousand USD | -327921.845% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -29670.9% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -898452.555% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -1674.733% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -5185.502% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -348639.691% |
| Dominari Holdings Inc. | 3.02 Million USD | -89163.54% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -2860505.163% |
| vTv Therapeutics Inc. | 529 Thousand USD | -510845.18% |
| Bio-Techne Corporation | 419.53 Million USD | -544.256% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -3654.236% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -1296.371% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -15904.856% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -11774.616% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -44517.035% |
| Nkarta, Inc. | 88.33 Million USD | -2959.691% |
| BioCardia, Inc. | 1.31 Million USD | -205443.726% |
| Iterum Therapeutics plc | 19.5 Million USD | -13754.631% |